The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

After settlements with Zantac cancer victims in California, litigants prepare for next phase in the litigation involving over 70,000 cases The FDA pulled Zantac because it contained a potent ...

June 30 (Reuters) - The first U.S. trial over claims that discontinued heartburn drug Zantac causes cancer is now expected to take place in California state court on Nov. 13, a lawyer for ...

Her suit alleges that the drug’s active ingredient, called ranitidine, turns into a cancer-causing substance called NDMA as it ages. GSK developed Zantac and later sold the over-the-counter ...

The jury found that Valadez proved that she had taken Zantac, but not that it was a cause of her cancer. First approved in 1983, Zantac became the world's best selling medicine in 1988 and one of ...

First-ever trial over Zantac cancer claims gets underway in Cook County The lawsuit is one of many claims made nationwide that the over-the-counter heartburn drug Zantac and its generics have an ...

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK , opens new tab and other companies, causes cancer is set to begin this week in Chicago.

After settlements with Zantac cancer victims in California, litigants prepare for next phase in the litigation involving over 70,000 cases The FDA pulled Zantac because it contained a potent ...